SUPPLEMENT ARTICLE
Management of Mangled Extremities and Orthopaedic
War Injuries
Todd O. McKinley, MD,* Jean-Claude D’Alleyrand, MD, LTC, MC,†‡
Ian Valerio, MD, CDR, MC, USNR,§ Seth Schoebel, PhD,k Kevin Tetsworth, MD,¶
and Eric A. Elster, MD, CPT, MC, USN‡
Summary: In 16 years of conflict, primarily in Iraq and AfghaniDownloaded from http://journals.lww.com/jorthotrauma by BhDMf5ePHKbH4TTImqenVI1NGeaZoDmODGCf0Y0DDjIxRYR++mMStvVUEQWskLjafqfYo8MgecY= on 05/11/2018
stan, wounded warriors have primarily been subjected to blast type
of injuries. Evacuation strategies have led to unprecedented survival
rates in blast-injured soldiers, resulting in large numbers of wounded
warriors with complex limb trauma. Bone and soft tissue defects
have resulted in increased use of complex reconstructive algorithms
to restore limbs and function. In addition, in failed salvage attempts,
advances in amputation options are being developed. In this review,
we summarize state-of-the-art limb-salvage methods for both soft
tissue and bone. In addition, we discuss advances in diagnostic
methods with development of personalized clinical decision support
tools designed to optimize outcomes after severe blast injuries.
Finally, we present new advances in osteointegrated prostheses for
above-knee amputations.
Key Words: war injuries, wounded warriors, limb salvage, computational biology
(J Orthop Trauma 2018;32:S37–S42)
INTRODUCTION
Fractures are the most common injuries sustained by
wounded warriors (WWs).1,2 The complex constellations of
orthopaedic and nonorthopaedic injuries frequently mandate
that these WWs undergo staged interventions in which decisions on the sequence, timing, and type of procedure must be
guided by the type of injuries and patient’s systemic
response.3–9 The complexity of staged treatment is further
Accepted for publication December 11, 2017.
From the *Department of Orthopaedic Surgery, Anatomy and Cell Biology
Indiana University School of Medicine, Indianapolis, IN; Departments of
†Orthopaedic Traumatology, and ‡Surgery, Uniformed Services University
of the Health Sciences, Bethesda, MD; §Departments of Plastic Surgery,
Orthopaedic Surgery and General Surgery, The Ohio State University
School of Medicine, Columbus, OH; kDepartment of Surgery, Uniformed
Services University of the Health Sciences, Bethesda, MD; and ¶Department of Orthopaedics, The Royal Brisbane Hospital; Brisbane, Australia.
The authors report no conflict of interest.
Supplemental digital content is available for this article. Direct URL citations
appear in the printed text and are provided in the HTML and PDF
versions of this article on the journal’s Web site (www.jorthotrauma.
com).
Reprints: Todd O. McKinley, MD, Department of Orthopaedic Surgery,
Anatomy and Cell Biology, IU Health Methodist Hospital MPC-1, 1801
North Senate Boulevard, Suite 535, Indianapolis, IN 46202 (e-mail:
[email protected]).
Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.
DOI: 10.1097/BOT.0000000000001121
magnified in WWs who are treated at a series of military
medical facilities along evacuation lines from the battlefield
back to domestic hospitals.10–12 Life-saving interventions are
the initial care priorities, and skeletal stabilization is often
temporary using damage control orthopaedics. However,
early total care of major fractures can improve outcomes
under certain conditions.8,9,13,14 Decisions regarding the
timing of orthopaedic procedures are currently based on the
physiologic condition of the patient, resource availability, and
the expected magnitude of the physiologic insult of the intervention.6,9,15–18 However, this treatment decision is usually
based on the collective anecdotal experience of the surgical
team.
Improvements in evacuation and treatment strategies of
the soldiers sustaining combat injuries have resulted in
unprecedented survival rates.10–12,19 An unintended consequence of improved survival of WWs is an increase in organ
dysfunction and wound complications, all of which can lead
to severe orthopaedic complications. Surgical interventions
are frequently staged in an effort to minimize complications
that typically affect multiply injured patients.3,4 Many of
these complications relate to not only the magnitude of the
initial immune response but also to the immune response to
subsequent interventions. The “additional hits” of surgical
procedures can amplify an already dysfunctional immune
response.20 An aberrant immune response is manifested by
an excessive and sustained systemic inflammatory response
syndrome that puts patients at risk of multiple organ dysfunction syndrome.21,22 Patients who develop multiple organ
dysfunction syndrome are at high risk of orthopaedic complications. Collectively, staged orthopaedic interventions have
evolved to try to minimize longer term complications and
poor function in badly injured soldiers.
To improve outcomes and limit complications, surgical
techniques have evolved over the past 15 years of conflict.
Military surgeons have increasingly recognized and leveraged
staged interventions, not only out of necessity and resource
availability but also by increasingly recognizing indications
for staged limb management. Increased survival has been
accompanied by increased wound burden in extremity
trauma. Accordingly, surgeons have investigated novel
approaches to facilitate healing of complex wounds with
composite tissue deficits including skin, muscle, and bone.
Finally, clinicians have increasingly recognized how systemic
injury can have devastating effects on orthopaedic injuries.
However, the complexities of the immunologic response that
J Orthop Trauma Volume 32, Number 3 Supplement, March 2018
www.jorthotrauma.com |
S37
Copyright Ó 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
McKinley et al
J Orthop Trauma Volume 32, Number 3 Supplement, March 2018
occurs after injury has made it difficult to quantify injuryassociated effects of multisystem trauma by linearreductionist types of models leading clinicians to adopt
bioinformatics approaches to better understand the burden
of injury.
The primary objective of this symposium was to present
a composite update on managing severe extremity trauma in
WWs who have been treated in Operation Iraqi Freedom and
Operation Enduring Freedom. Two of our speakers were
military surgeons with extensive experience in treating
complex extremity trauma. They discussed orthopaedic and
plastic surgical management of complex extremity trauma.
Our third speaker presented data from a novel bioinformatics
approach to improve outcomes in soldiers sustaining severe
blast injuries and complex extremity trauma. Bioinformatics
continues to evolve as a powerful tool that incorporates
patient-specific information to optimize treatment decisions.
This approach has been successfully implemented in WWs
sustaining blast injuries to their limbs. Finally, our fourth
speaker has been integral in the development of osteointegrated prostheses for patients sustaining above-knee amputations. These methods hold exceptional potential to improve
outcomes in WWs and all patients who sustain above-knee
amputations.
ADVANCES IN ORTHOPAEDIC MANAGEMENT
OF WAR EXTREMITY INJURIES DURING
RECENT CONFLICTS
Combat-related extremity injuries typically have
wide, evolving zones of injury punctuated with highenergy open fractures with bone and soft tissue loss. These
injuries have resulted in evolution of reconstructive,
regenerative, and amputation methods to improve outcomes. Wound expansion after injury is commonplace
and results in higher infection rates than in civilian injuries.
Postinjury complications are relatively common, as are
large composite tissue defects that frequently pose significant challenges with respect to reconstruction. Recently,
basic scientific evidence to guide decisions pertaining to
wound management has emerged. For example, dehiscence
of combat wounds has been associated with vascular
injuries and with systemic and wound inflammation, as
measured by increased levels of procalcitonin and IL-6 in
either serum or wound effluent. However, the appropriate
timing of closure of these wounds is generally left to the
surgeon’s judgment.
Skin management often plays a pivotal role in outcomes
after war injuries. When closing the skin envelope, primary
closure is preferable to split-thickness skin grafting (STSG)
in weight-bearing areas because of superior mechanical
properties. Thus, primary closure with native skin should
be prioritized while closing lower extremity wounds and
amputation stumps. In the lower extremities, it is typically
preferable to accept modest skeletal shortening because
a slightly shorter limb with a good distal soft tissue envelope
is preferable to a longer limb with poor skin coverage.
Collagen dermal substitutes are routinely used before grafting,
particularly when grafting over high-shear areas or if revision
S38
| www.jorthotrauma.com
surgeries are remotely anticipated.23,24 These substitutes facilitate a more robust wound closure compared with STSG.
Another common denominator leading to skin problems is
heterotopic ossification (HO). HO has recently been associated
with persistent methicillin resistant staphylococcus aureus
infection25 and with systemic and wound inflammation.26,27
Another, less common revision surgery in amputees is targeted
muscle reinnervation, a method for improving myoelectric
prosthetic control28 and potentially for decreasing neuromarelated pain.29
Often, primary closure and STSG are insufficient to
obtain closure. Rotational or free flaps are the standard
solutions for this,30 but a paucity of local donor tissue
or vasculature may rule these out as options. One
possible solution is to temporarily shorten and angulate
the fracture to allow primary wound closure. Once the
wound has healed, the fracture is gradually reduced with
a ringed external fixator and restored through distraction
osteogenesis (see Figure, Supplement Digital Content 1,
http://links.lww.com/JOT/A284 ). 31–34 Distraction osteogenesis can also address segmental bone loss, as can bone
grafting with or without the use of a spacer-induced membrane (IM). This latter technique35 is up to 90% effective.36 The IM is not only structural but also has
osteoinductive properties during the first 4–8 weeks.37
Recent investigation into optimizing the efficacy of the
IM technique suggests that scraping the exudative inner
layer of the membrane can significantly increase the
amount of bone formation.38
Some of the major clinical challenges after reconstruction include posttraumatic osteoarthritis and neuromuscular
deficits; however, early results with a custom exoskeletal
orthosis, paired with a high-intensity sports rehabilitation
program, have allowed many military patients with highenergy lower extremity trauma to resume athletic activity,
with up to 20% returning to deployment status.39,40 There is
also evidence that suggests that US military patients do better
with amputation, with better functional scores and return to
vigorous activity compared with civilians.41,42 These results
must be interpreted with caution, however, because there are
many potential differences between military and civilian patients, such as preinjury function, peer support, socioeconomic factors, and access to advanced prosthetics and
rehabilitation.
ADVANCES IN SOFT TISSUE INJURY
RECONSTRUCTION DURING RECENT CONFLICTS
Recent conflicts have commonly used improvised
explosive devices and explosive munitions. These blast and
fragmentation weapons have directly contributed to high rates
of orthoplastic injuries because trauma to the musculoskeletal
system remains the most common result of exposure to such
destructive devices.43,44 Given the complex nature of injuries
resulting from such devices, refinements in soft tissue reconstruction and restoration have become critical to achieving
successful definitive soft tissue coverage while also optimizing the functional outcomes.
Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.
Copyright Ó 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
J Orthop Trauma Volume 32, Number 3 Supplement, March 2018
ADJUNCTS TO THE RECONSTRUCTIVE
LADDER/ELEVATOR
Exposure to blast and fragmentation devices often
results in orthoplastic injury patterns, exhibiting massive
composite-type tissue defects. Careful evaluation of soft
tissue perfusion coupled with serial debridement of soft tissue
injury is of paramount importance to decontaminate tissues
while determining the actual amount of destruction and
structures involved in the composite and soft tissue loss(es).
Once the exact tissue restoration needs are determined, the
soft tissue reconstruction measures can be achieved.
Although the reconstructive ladder/elevator contains common surgical methods to be used in soft tissue coverage—eg,
skin grafting, flaps, and microsurgical free-tissue transfers—
application of various regenerative medicine adjuncts to these
measures has increasingly contributed to the improved outcomes in orthoplastic reconstruction. Thus, the establishment
of the “hybrid” reconstructive ladder, which incorporates
traditional autologous surgical reconstruction techniques with
allograft and man-made regenerative medicine adjuncts, has
been an important step in addressing severe soft tissue injuries
caused by military-related trauma (see Figure, Supplement
Digital Content 2, http://links.lww.com/JOT/A285 ).23,45–47
Autologous adipose tissue grafts, mesenchymal stem cell
therapies, nerve autografts/allografts/wraps, dermal regenerate templates (DRTs), and extracellular matrix scaffolds
have been incorporated into the “hybrid” reconstructive
ladder.23,44–49
DRTs AND EXTRACELLULAR MATRICES
DRTs and extracellular matrices (ECMs) have been
illustrated to aid in creating a neovascularized soft tissue bed
by way of providing a biologic scaffold to support cellular
invasion and graft incorporation.45,48 These regenerative
medicine tools can be used for soft tissue restoration of full
and partial23,47 thickness traumatic and/or burn injuries as
well as wounds exhibiting hypovascular structures and/or
exposed vital structures such as tendons, nerves, blood vessels, cartilage, and/or bone. These regenerative medicine soft
tissue coverage adjuncts have proved to aid in the preservation of residual limb length while providing more stable soft
tissue durability and contouring, which has improved function
and comfort with prosthetic device wear.23,46,48 Furthermore,
DRTs and ECMs have proven to be intimately important in
sustaining certain spray skin and cellular skin transplant applications for skin regeneration and restoration strategies that
have been applied to combat soft tissue injuries.45,50 Current
and future investigational soft tissue restoration strategies
have expanded to incorporate 3D cell bioprinting to in vivo
and in vitro–based bioscaffolds, DRTs, and ECMs to restore
partial and full thickness soft tissue defects, provide skin
restoration strategies, and serve as more functional composite
soft tissue replacements.
NERVE RESTORATION AND REGENERATION
Blast- and fragmentation-type injuries have high rates
of peripheral nerve injuries. Given the nonavailability of
Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.
Mangled Extremities and Orthopaedic War Injuries
adequate autologous nerve in certain combat casualties,
increased application of peripheral nerve reconstructions
using nerve allografts and nerve coaptation wraps/tubes has
become more common. Goals of nerve repair not only focus
on tension-free coaptation, especially critical to segmental
nerve repairs, but also on distal nerve transfers to preserve the
motor end units and neuromuscular junction function until
nerve regeneration can be successful. In cases where nerve
repair is not feasible, nerve and tendon transfers are critical to
improving extremity function. In residual limb cases, targeted
reinnervation, implantable electrodes, and improved bioprosthetics have aided to restore certain functional goals for our
WWs. In select residual limb cases, hand and/or limb
allotransplantation has provided restoration of limbs, encouraging functional gains and nerve regeneration in certain cases.
INTEGRATING COMPUTATIONAL CLINICAL
DECISION-MAKING TOOLS TO OPTIMIZE OUTCOMES IN SEVERE EXTREMITY
WOUNDS: EXPERIENCE OF THE SURGICAL
CRITICAL CARE INITIATIVE
Management of war wounds and civilian traumatic
injuries is a complex endeavor. The current practice of
managing battle-injured warriors is dependent on visually
guided traditional treatments and clinical decision making.
The Surgical Critical Care Initiative (SC2i) currently estimates that traditional approaches for complex wound management are 85% successful in predicting successful wound
closure at 110% of predicted costs. The SC2i proposes to
enhance traditional approaches using evidence-based data
science, clinical data, and biomarker data to optimize
individualized wound treatment and critical care management.51,52 These focused treatments will use deeper understanding of physiological, psychological, and physical
factors that govern injury response with the goal of providing
precision medicine to critically ill patients.
The SC2i seeks a 95% solution at 95% cost of wound
management and critical care management of WWs by
developing clinical decision support tools (CDSTs) that guide
therapy. This will be achieved by focusing on developing
patient-specific wound management CDSTs. The SC2i has
identified a variety of potential CDSTs focused on critical
care issues from the point of injury to return to duty. The
SC2i is developing tools aimed at delivering massive transfusion and avoiding severe traumatic brain injury and
invasive fungal infection.52–54 The SC2i has also begun
developing tools for identifying patients with and at risk of
infectious complications and venous thromboembolism.
These tools could be used during the debridement and critical
care phase of the treatment. Finally, in the recovery phase, the
SC2i is focusing on CDSTs for physiological monitoring,
wound closure, acute kidney injury, and HO.
To achieve the goal of delivering precision medicine to
the war fighter, the SC2i has implemented an event and the
time-driven research protocol for collection of biological
samples and clinical data called the Tissue and Data
Acquisition Protocol (TDAP). The TDAP protocol has been
www.jorthotrauma.com |
S39
Copyright Ó 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
McKinley et al
J Orthop Trauma Volume 32, Number 3 Supplement, March 2018
implemented at 3 clinical sites (Duke, Walter Reed, and
Emory-Grady). The TDAP focuses on collection of serum,
tissue, and wound effluent, among other biological samples at
specific time intervals after injury or surgical intervention.
Sample collection is also driven by adverse events that occur
during the course of treatment. With these biological samples
and related clinical data, SC2i researchers standardize and
aggregate the data on Amazon Web Services GovCloud in
a central data repository for analysis and tool development.
Two specific tools the SC2i is working to develop are
a wound closure timing CDST and a tool for identification of
patients at risk of developing pneumonia and/or bacteremia.55–57 Previous work demonstrated that a random forest
model using the top 10 variables from a military data set had
the best performance to predict successful wound closure
demonstrating an area under the curve of 0.79 (95% confidence interval, 0.56–0.88). The wound closure model is currently in the process of being externally validated by a civilian
data set. Although there are some notable differences in the
demographics between the military and civilian data sets,
namely, age, sex, body mass index, and injury severity, the
biomarker distributions found in the serum and wound
effluent were largely the same. The pneumonia- and
bacteremia-predictive tool is still in the nascent stages of
model construction and tuning. The initial models show area
under the curves of 0.856 for pneumonia and 0.834 for bacteremia and use a combination of systemic biomarkers and
clinical variables.
The SC2i is currently in the process of enrolling about
500 patients per year at its 3 clinical sites. This work will
support the development of novel CDSTs in the surgical
critical care arena. The end goal of the work of the SC2i is to
integrate clinical and biomarker data into CDSTs that are
linked with the patient electronic health record. This will
enable the fulfillment of the SC2i mission of delivering
precision medicine—the right care, at the right time, to the
right patient, and in the most cost-effective manner.
osseointegration.58,59 This surgical procedure involves the
direct attachment of the prosthesis to the skeletal residuum.58,59 This is currently achieved using a highly porouscoated titanium intramedullary implant, analogous to the
process used for obtaining press-fit ingrowth during total
hip replacement. This consistently results in a structural and
functional connection between the macroporous surface of
these biocompatible metal implants and living bone.58,59
The titanium intramedullary component is first inserted into
the remaining bone in a retrograde fashion, and the implant is
rapidly incorporated over several months. This intramedullary
implant soon becomes continuous with the amputees’ skeletal
residuum, and an abutment that penetrates the skin through
a small permanent opening is later used for the attachment of
the prosthetic limb itself. By intimately connecting the artificial limb directly to the residual bone, the problematic
socket–residuum interface is eliminated.58,59
This technology has been used for over 20 years.58,59
This procedure results in major clinical benefits, including
improved quality of life, prosthetic use, body image, hip
range of motion, sitting comfort, donning and doffing, osseoperception, and walking ability.58,59 It must be emphasized
here that this has been achieved while also maintaining very
acceptable levels of risk with respect to the associated potential major complications, including implant stability and rates
of infection.58,59 Until very recently these procedures were
completed in 2 stages,58,59 but techniques have evolved rapidly, and now 1-stage procedures are performed on a routine
basis.60 The postoperative and early follow-up data after
single-stage procedures are very encouraging, showing no
evidence of an increased risk of related complications, particularly implant loosening or infection. Bone remodelling indicators seem even better than observed after the 2-stage
procedure. Although the preliminary results of a pilot study
are so far very encouraging, there is clearly a need for more
evidence of the efficacy of the 1-stage reconstruction
protocol.60
OSSEOINTEGRATION: THE TRANSCUTANEOUS
ENDOPROSTHETIC RECONSTRUCTION ALTERNATIVE TO DEVASTATING LOWER
LIMB INJURIES
1. Belmont PJ Jr, McCriskin BJ, Hsiao MS, et al. The nature and incidence
of musculoskeletal combat wounds in Iraq and Afghanistan (2005–
2009). J Orthopaedic Trauma. 2013;27:e107–113.
2. Schoenfeld AJ, Dunn JC, Bader JO, et al. The nature and extent of war
injuries sustained by combat specialty personnel killed and wounded in
Afghanistan and Iraq, 2003–2011. J Trauma Acute Care Surg. 2013;75:
287–291.
3. D’Alleyrand JC, O’Toole RV. The evolution of damage control orthopedics: current evidence and practical applications of early appropriate
care. Orthop Clin North America. 2013;44:499–507.
4. Lichte P, Kobbe P, Dombroski D, et al. Damage control orthopedics:
current evidence. Curr Opin Crit Care. 2012;18:647–650.
5. Morshed S, Miclau T III, Bembom O, et al. Delayed internal fixation of
femoral shaft fracture reduces mortality among patients with multisystem
trauma. J Bone Joint Surg Am. 2009;91:3–13.
6. Pape HC, Giannoudis PV, Krettek C, et al. Timing of fixation of major
fractures in blunt polytrauma: role of conventional indicators in clinical
decision making. J Orthop Trauma. 2005;19:551–562.
7. Pape HC, Hildebrand F, Pertschy S, et al. Changes in the management of
femoral shaft fractures in polytrauma patients: from early total care to
damage control orthopedic surgery. J Trauma. 2002;53:452–461; discussion 461–452.
8. Steinhausen E, Lefering R, Tjardes T, et al. A risk-adapted approach is
beneficial in the management of bilateral femoral shaft fractures in
REFERENCES
High-energy military trauma often results in a mangled
lower extremity that cannot be successfully salvaged, resulting in amputation levels above the knee. In addition, these
injuries are often bilateral and are notoriously difficult to fit
with prostheses because of a short skeletal residuum, dense
adherent scars, and heterotopic bone. Because of these issues,
over 90% of bilateral above-knee amputees eventually end up
confined to a wheelchair.58–60 Despite extensive and continuing research, significant socket-associated problems persist.
One-third of all amputees still encounter symptomatic
socket–residuum interface problems, resulting in reduced
prosthetic use and a markedly diminished quality of life.58
Over the past 20 years, a dramatically different concept
has emerged that effectively overcomes the many problems
associated with traditional socket-mounted prosthetics, called
S40
| www.jorthotrauma.com
Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.
Copyright Ó 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
J Orthop Trauma Volume 32, Number 3 Supplement, March 2018
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
multiple trauma patients: an analysis based on the trauma registry of the
German Trauma Society. J Trauma Acute Care Surg. 2014;76:1288–
1293.
Vallier HA, Wang X, Moore TA, et al. Timing of orthopaedic surgery in
multiple trauma patients: development of a protocol for early appropriate
care. J Orthop Trauma. 2013;27:543–551.
Andersen RC, Ursua VA, Valosen JM, et al. Damage control orthopaedics: an in-theater perspective. J Surg Orthop Adv. 2010;19:13–17.
Balazs GC, Blais MB, Bluman EM, et al. Blurred front lines: triage and
initial management of blast injuries. Curr Rev Musculoskelet Med. 2015;
8:304–311.
Covey DC. Combat orthopaedics: a view from the trenches. J Am Acad
Orthop Surg. 2006;14:S10–S17.
Bliemel C, Lefering R, Buecking B, et al. Early or delayed stabilization
in severely injured patients with spinal fractures? Current surgical objectivity according to the Trauma Registry of DGU: treatment of spine
injuries in polytrauma patients. J Trauma Acute Care Surg. 2014;76:
366–373.
Stahel PF, VanderHeiden T, Flierl MA, et al. The impact of a standardized “spine damage-control” protocol for unstable thoracic and lumbar
spine fractures in severely injured patients: a prospective cohort study.
J Trauma Acute Care Surg. 2013;74:590–596.
Flierl MA, Stoneback JW, Beauchamp KM, et al. Femur shaft fracture
fixation in head-injured patients: when is the right time? J Orthop
Trauma. 2010;24:107–114.
Lefaivre KA, Starr AJ, Stahel PF, et al. Prediction of pulmonary morbidity and mortality in patients with femur fracture. J Trauma. 2010;69:
1527–1535; discussion 1535–1526.
O’Toole RV, O’Brien M, Scalea TM, et al. Resuscitation before stabilization of femoral fractures limits acute respiratory distress syndrome in
patients with multiple traumatic injuries despite low use of damage control orthopedics. J Trauma. 2009;67:1013–1021.
Pape HC, Rixen D, Morley J, et al. Impact of the method of initial
stabilization for femoral shaft fractures in patients with multiple injuries
at risk for complications (borderline patients). Ann Surg. 2007;246:491–
499; discussion 499–501.
Sauer SW, Robinson JB, Smith MP, et al. Saving lives on the battlefield
(part II) ? One year later a joint theater trauma system and joint trauma
system review of prehospital trauma care in combined joint operations
area? Afghanistan (CJOA-A) final report, 30 may 2014. J Spec Oper
Med. 2015;15:25–41.
Moore FA, Sauaia A, Moore EE, et al. Postinjury multiple organ failure:
a bimodal phenomenon. J Trauma. 1996;40:501–510; discussion 510–
502.
Baue AE. Sepsis, systemic inflammatory response syndrome, multiple
organ dysfunction syndrome, and multiple organ failure: are trauma surgeons lumpers or splitters? J Trauma. 2003;55:997–998.
Baue AE, Durham R, Faist E. Systemic inflammatory response
syndrome (SIRS), multiple organ dysfunction syndrome (MODS),
multiple organ failure (MOF): are we winning the battle? Shock.
1998;10:79–89.
Fleming ME, O’Daniel A, Bharmal H, et al. Application of the orthoplastic reconstructive ladder to preserve lower extremity amputation
length. Ann Plast Surg. 2014;73:183–189.
Helgeson MD, Potter BK, Evans KN, et al. Bioartificial dermal substitute: a preliminary report on its use for the management of complex combat-related soft tissue wounds. J Orthop Trauma. 2007;21:
394–399.
Pavey GJ, Qureshi AT, Hope DN, et al. Bioburden increases heterotopic
ossification formation in an established rat model. Clin Orthop Relat Res.
2015;473:2840–2847.
Evans KN, Forsberg JA, Potter BK, et al. Inflammatory cytokine and
chemokine expression is associated with heterotopic ossification in
high-energy penetrating war injuries. J Orthop Trauma. 2012;26:
e204–213.
Forsberg JA, Potter BK, Polfer EM, et al. Do inflammatory markers
portend heterotopic ossification and wound failure in combat wounds?
Clin Orthop Relat Res. 2014;472:2845–2854.
Kuiken TA, Dumanian GA, Lipschutz RD, et al. The use of targeted
muscle reinnervation for improved myoelectric prosthesis control in
a bilateral shoulder disarticulation amputee. Prosthet Orthot Int. 2004;
28:245–253.
Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.
Mangled Extremities and Orthopaedic War Injuries
29. Souza JM, Cheesborough JE, Ko JH, et al. Targeted muscle reinnervation: a novel approach to postamputation neuroma pain. Clin Orthop
Relat Res. 2014;472:2984–2990.
30. Burns TC, Stinner DJ, Possley DR, et al. Does the zone of injury in
combat-related Type III open tibia fractures preclude the use of local soft
tissue coverage? J Orthop Trauma. 2010;24:697–703.
31. Gulsen M, Ozkan C. Angular shortening and delayed gradual distraction
for the treatment of asymmetrical bone and soft tissue defects of tibia:
a case series. J Trauma. 2009;66:E61–E66.
32. Hsu JR, Beltran MJ. Shortening and angulation for soft-tissue reconstruction of extremity wounds in a combat support hospital. Mil Med. 2009;
174:838–842.
33. Nho SJ, Helfet DL, Rozbruch SR. Temporary intentional leg shortening
and deformation to facilitate wound closure using the Ilizarov/Taylor
spatial frame. J Orthop Trauma. 2006;20:419–424.
34. Sharma H, Nunn T. Conversion of open tibial IIIb to IIIa fractures using
intentional temporary deformation and the Taylor Spatial Frame. Strategies Trauma Limb Reconstr. 2013;8:133–140.
35. Masquelet AC, Fitoussi F, Begue T, et al. Reconstruction of the long
bones by the induced membrane and spongy autograft. Ann Ann Chir
Plast Esthet. 2000;45:346–353.
36. Pountos I, Panteli M, Jones E, et al. How the induced membrane contributes to bone repair: a scientific-based analysis. Tech Orthopaedics.
2016;31:9–13.
37. Pelissier P, Martin D, Baudet J, et al. Behaviour of cancellous
bone graft placed in induced membranes. Br J Plast Surg. 2002;55:
596–598.
38. Muschler GF. Optimizing soft tissue management and spacer design in
segmental bone defects. DTIC Document. Cleveland, OH: Cleveland Clinic
Foundation; 2014.
39. Owens JG, Blair JA, Patzkowski JC, et al. Return to running and sports
participation after limb salvage. J Trauma. 2011;71:S120–S124.
40. Patzkowski JC, Owens JG, Blanck RV, et al. Deployment after limb
salvage for high-energy lower-extremity trauma. J Trauma Acute Care
Surg. 2012;73:S112–S115.
41. Bosse MJ, MacKenzie EJ, Kellam JF, et al. An analysis of outcomes of
reconstruction or amputation after leg-threatening injuries. N Engl J Med.
2002;347:1924–1931.
42. Doukas WC, Hayda RA, Frisch HM, et al. The Military Extremity
Trauma Amputation/Limb Salvage (METALS) study: outcomes of
amputation versus limb salvage following major lower-extremity trauma.
J Bone Joint Surg Am. 2013;95:138–145.
43. Covey DC. Blast and fragment injuries of the musculoskeletal system.
J Bone Joint Surg Am. 2002;84-A:1221–1234.
44. Valerio IL, Sabino J, Mundinger GS, et al. From battleside to stateside:
the reconstructive journey of our wounded warriors. Ann Plast Surg.
2014;72(suppl 1):S38–S45.
45. Valerio IL, Sabino JM, Dearth CL. Plastic surgery challenges in war
wounded II: regenerative medicine. Adv Wound Care (New Rochelle).
2016;5:412–419.
46. Fleming ME, Bharmal H, Valerio I. Regenerative medicine applications
in combat casualty care. Regen Med. 2014;9:179–190.
47. Sabino J, Polfer E, Tintle S, et al. A decade of conflict: flap coverage
options and outcomes in traumatic war-related extremity reconstruction.
Plast Reconstr Surg. 2015;135:895–902.
48. Seavey JG, Masters ZA, Balazs GC, et al. Use of a bioartificial dermal
regeneration template for skin restoration in combat casualty injuries.
Regen Med. 2016;11:81–90.
49. Sabino JM, Slater J, Valerio IL. Plastic surgery challenges in war
wounded I: flap-based extremity reconstruction. Adv Wound Care
(New Rochelle). 2016;5:403–411.
50. Rendon JL, Hammer D, Sabino J, et al. Restoration of full thickness soft
tissue defects with spray skin epidermal regenerative technology in conjunction with dermal regenerate. Plast Reconstr Surg. 2015;136:74.
51. Belard A, Buchman T, Forsberg J, et al. Precision diagnosis: a view of
the clinical decision support systems (CDSS) landscape through the lens
of critical care. J Clin Monit Comput. 2017;31:261–271.
52. Buchman TG, Billiar TR, Elster E, et al. Precision medicine for critical
illness and injury. Crit Care Med. 2016;44:1635–1638.
53. Be NA, Allen JE, Brown TS, et al. Microbial profiling of combat wound
infection through detection microarray and next-generation sequencing.
J Cinical Microbiol. 2014;52:2583–2594.
www.jorthotrauma.com |
S41
Copyright Ó 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
McKinley et al
J Orthop Trauma Volume 32, Number 3 Supplement, March 2018
54. Radowsky JS, Brown TS, Lisboa FA, et al. Serum inflammatory cytokine
markers of invasive fungal infection in previously immunocompetent
battle casualties. Surg Infect (Larchmt). 2015;16:526–532.
55. Chromy BA, Eldridge A, Forsberg JA, et al. Proteomic sample preparation for blast wound characterization. Proteome Sci. 2014;12:10.
56. Chromy BA, Eldridge A, Forsberg JA, et al. Wound outcome in combat
injuries is associated with a unique set of protein biomarkers. J Transl
Med. 2013;11:281.
57. Hahm G, Glaser JJ, Elster EA. Biomarkers to predict wound healing: the
future of complex war wound management. Plast Reconstr Surg. 2011;
127(suppl 1):21S–26S.
58. Muderis MA, Tetsworth K, Khemka A, et al. The Osseointegration
Group of Australia Accelerated Protocol (OGAAP-1) for two-stage osseointegrated reconstruction of amputated limbs. Bone Joint J. 2016;98B:952–960.
59. Al Muderis M, Khemka A, Lord SJ, et al. Safety of osseointegrated
implants for transfemoral amputees: a two-center prospective cohort
study. J Bone Joint Surg Am. 2016;98:900–909.
60. Al Muderis M, Lu W, Tetsworth K, et al. Single-stage osseointegrated
reconstruction and rehabilitation of lower limb amputees: the Osseointegration Group of Australia Accelerated Protocol-2 (OGAAP-2) for a prospective cohort study. BMJ open. 2017;7:e013508.
S42
Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.
| www.jorthotrauma.com
Copyright Ó 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.